Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Ebopiprant

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    XOMA Acquires Royalty and Milestone License to Ebopiprant
    XOMA Acquires Royalty and Milestone License to Ebopiprant

    22 Nov 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/11/22/2560671/7281/en/XOMA-Acquires-Royalty-and-Milestone-License-to-Ebopiprant-a-Preterm-Labor-Asset-Being-Developed-by-Organon.html

    GLOBENEWSWIRE
    22 Nov 2022
    Share Share
    ObsEva Announces Sale of Ebopiprant Agreement to XOMA for up to $113 Million
    ObsEva Announces Sale of Ebopiprant Agreement to XOMA for up to $113 Million

    22 Nov 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/11/22/2560648/0/en/ObsEva-Announces-Sale-of-Ebopiprant-License-Agreement-to-XOMA-for-up-to-113-Million.html

    GLOBENEWSWIRE
    22 Nov 2022
    Share Share
    ObsEva to Present Ebopiprant Data at Society for Reproductive Investigation
    ObsEva to Present Ebopiprant Data at Society for Reproductive Investigation

    02 Jul 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/07/02/2256912/0/en/ObsEva-to-Present-Ebopiprant-OBE022-Data-at-the-Society-for-Reproductive-Investigation-68th-Annual-Meeting.html

    GLOBENEWSWIRE
    02 Jul 2021
    Share Share